NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Actelion Ltd (ETR: ACT)

 
ACT Technical Analysis
4
As on 27th Oct 2017 ACT Share Price closed @ 240.00 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 215.43 & Buy for SHORT-TERM with Stoploss of 238.67 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

ACT Share Price

Open 239.00 Change Price %
High 240.05 1 Day 0.00 0.00
Low 239.00 1 Week 0.00 0.00
Close 240.00 1 Month 5.50 2.35
Volume 114 1 Year 110.10 84.76
52 Week High 266.90 | 52 Week Low 134.65
 
ETR Germany Most Active Stocks
DTE 15.31 -2.11%
DBK 14.13 1.29%
EOAN 10.38 2.47%
CBK 11.88 0.93%
IFX 24.51 4.30%
LHA 28.21 2.96%
DAI 73.07 2.50%
BIR 0.24 0.00%
TKA 23.49 2.53%
MEO 29.18 0.00%
 
ETR Germany Top Gainers Stocks
S9H 0.16 45.45%
M3B 0.84 21.74%
CR8 7.33 20.16%
R3Q 0.12 20.00%
5M71 39.00 13.70%
WI4 1.12 13.13%
KU2 210.50 11.97%
SONA 35.85 11.75%
SONA 35.85 11.75%
ELG 27.09 11.53%
 
ETR Germany Top Losers Stocks
MPI 0.25 -98.98%
MPI 0.25 -98.98%
APL 2.60 -34.18%
APL 2.60 -34.18%
APL 2.60 -34.18%
U9R 10.60 -24.56%
BIO 24.70 -11.41%
BIO 24.70 -11.41%
BIO 24.70 -11.41%
BIO 24.70 -11.41%
 
 
ACT
Daily Charts
ACT
Intraday Charts
Whats New @
Bazaartrend
ACT
Free Analysis
 
ACT Important Levels Intraday
SUPPORT0.00
SUPPORT0.00
RESISTANCE240.97
RESISTANCE240.57
SUPPORT239.43
SUPPORT239.03
SUPPORT0.00
SUPPORT0.00
 
ACT Target for Month September
4th UP TARGET250.69
3rd UP TARGET247.26
2nd UP TARGET245.14
1st UP TARGET243.02
1st DOWN TARGET236.98
2nd DOWN TARGET234.86
3rd DOWN TARGET232.74
4th DOWN TARGET229.31
 
ACT Weekly Target
4th UP TARGET0.00
3rd UP TARGET0.00
2nd UP TARGET0.00
1st UP TARGET0.00
1st DOWN TARGET0.00
2nd DOWN TARGET0.00
3rd DOWN TARGET0.00
4th DOWN TARGET0.00
 
ACT Target for Year 2020
4th UP TARGET0
3rd UP TARGET0
2nd UP TARGET0
1st UP TARGET0
1st DOWN TARGET0
2nd DOWN TARGET0
3rd DOWN TARGET0
4th DOWN TARGET0
 
 
ACT Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
ACT Address
ACT
Gewerberstrasse 16
Allschwil, 4123
Switzerland
Phone: 41 61 565 65 65
Fax: 41 61 565 65 00
 
ACT Latest News
 
Your Comments and Response on Actelion Ltd
 
ACT Business Profile
Actelion Ltd, a biopharmaceutical company, discovers, develops, and commercializes drugs for diseases with unmet medical needs. Its products include Tracleer, a dual endothelin receptor antagonist for the treatment of pulmonary arterial hypertension (PAH), a chronic and life-threatening disorder that severely compromises the functions of the lungs and heart; Opsumit, an orally available endothelin receptor antagonist; and Valchlor, a chemotherapeutic agent for the treatment of mycosis fungoides, a common type of cutaneous T-cell lymphoma. The company also provides Veletri, a formulation of epoprostenol for the treatment of PAH; Ventavis, an inhaled formulation of iloprost for the treatment of PAH; and Zavesca, an oral treatment for patients with mild to moderate type 1 Gaucher disease for whom enzyme replacement therapy is unsuitable. Actelion Ltd markets its products in Switzerland, the United States, Japan, China, Russia, and Mexico. The company was founded in 1997 and is headquartered in Allschwil, Switzerland.
 
2005-2019 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service